VITAMINS@WORK
0783.584.113 · rovalta.com · 09/11/2026
ACTIVE
VITAMINS@WORK
Financial year 2025 · Closed on 31/12/2025
Net result-539,3 k €-88,8 %over 1 year
Gross margin-351,4 k €-85,9 %over 1 year
Equity580,8 k €-48,8 %over 1 year
Workforce1,2 ETP
Overview
Identity
Source · BCE/KBOVITAMINS@WORK is a Private limited company incorporated in 2022. Its main activity is: Computer programming activities. Its registered office is in Leuven. It employs on average 1,2 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0783.584.113
- Incorporation
- 18/03/2022
- Legal form
- Private limited company
- Registered office
- Diestsepoort 1
3000 Leuven · FlandreSee on map - Contributed capital
- 1 751 997,07 €
- Latest accounts
- 31/12/2025
- Average workforce
- 1,2 ETP
Activities (NACE)
62010Computer programming activities· main62100Computer programming, consultancy and related activities63100Data processing, hosting and related activities; web portals63110Data processing, hosting and related activities47400Retail sale of information and communication equipment in specialised stores47410Retail sale of computers, peripheral units and software in specialised stores+7
Signals
Solid equityHealthy social debts
Financials
Source · NBB, 5 filingsTrend over 4 financial years
| 2025 | 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | -351,4 k € | -85.9% | -189,1 k € | -3.2% | -183,2 k € | -401% | -36,5 k € |
| EBITDA | -430,6 k € | -124% | -192,5 k € | +7.3% | -207,6 k € | -462% | -36,9 k € |
| Operating result | -536,8 k € | -90.5% | -281,8 k € | -1.9% | -276,6 k € | -299% | -69,3 k € |
| Net result | -539,3 k € | -88.8% | -285,7 k € | -3.2% | -276,8 k € | -299% | -69,3 k € |
| Balance sheet | |||||||
| Equity | 580,8 k € | -48.8% | 1,1 M € | +25.8% | 900,8 k € | -23.5% | 1,2 M € |
| Total assets | 811 k € | -29.6% | 1,2 M € | +26.1% | 912,8 k € | -23.1% | 1,2 M € |
| Cash | 85 k € | -72.1% | 304,8 k € | +32.7% | 229,6 k € | -63.9% | 636,5 k € |
| Debts | 230,2 k € | +1196% | 17,8 k € | +49.2% | 11,9 k € | +27.6% | 9,3 k € |
| Other | |||||||
| Workforce | 1,2 ETP | – | 0,4 ETP | – | |||
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20257 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Bernadette Claes | DirectorMandate2022 accountsended | ||
Bert Schreurs | Director | ||
Daan De wever | DirectorMandate2022 accountsended | ||
Jonas Scheers | Director | ||
| AssociateDirector2024 accountsended | |||
Patrick De Pauw | Director | ||
Steven Van Mol | DirectorMandate2022 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Christophe Reynaert | Director2024 accounts | ||
Christophe Reynart | Mandate2022 accounts | ||
| Director2024 accounts |
Other companies at this address
Diestsepoort 1 3000 Leuven| Company | CBE no. |
|---|---|
ArtiQ● Active | 0720.636.061 |
BIOMEDICAL SYSTEMS● Active | 0421.984.741 |
EverESSt● Active | 1007.726.763 |
HYP3● Active | 0899.235.629 |
LVL7● Active | 0675.346.266 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 18/03/2022 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
| Length of the financial year | 12 months | 12 months | 12 months | 10 months |
| Filing date | 08/10/2026 | 16/07/2025 | 24/06/2024 | 14/07/2023 |
| General meeting | 09/09/2026 | 01/07/2025 | 07/06/2024 | 30/06/2023 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 5 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged modelCorrection | 31/12/2025 | 09/09/2026 | 08/10/2026 | Dutch | |
| Abridged model | 31/12/2025 | 12/05/2026 | 12/05/2026 | Dutch | |
| Abridged model | 31/12/2024 | 01/07/2025 | 16/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 07/06/2024 | 24/06/2024 | Dutch | |
| Micro model | 31/12/2022 | 30/06/2023 | 14/07/2023 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20257 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Bernadette Claes | DirectorMandate2022 accountsended | ||
Bert Schreurs | Director | ||
Daan De wever | DirectorMandate2022 accountsended | ||
Jonas Scheers | Director | ||
| AssociateDirector2024 accountsended | |||
Patrick De Pauw | Director | ||
Steven Van Mol | DirectorMandate2022 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Christophe Reynaert | Director2024 accounts | ||
Christophe Reynart | Mandate2022 accounts | ||
| Director2024 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates02/10/2026Rectificatie van de publicatie inzake het ontslag van een bestuurder van de
- Mandates12/08/2026Ontslag bestuurder
- Mandates05/05/2026ONTSLAGEN - BENOEMINGEN
- Capital / shares12/09/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Registered office15/03/2024MAATSCHAPPELIJKE ZETEL
- Mandates19/12/2022ONTSLAGEN - BENOEMINGEN
- Other13/09/2022STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Other22/03/2022RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings4 filings
Mandates
LVL7
Daan De Wever
Bernadette Claes
Bert Schreurs
Steven Van Mol
Jonas Scheers
Patrick De Pauw
JGW Management Services
Christophe Reynart
Christophe Reynaert
20222023202420252026
VITAMINS@WORK
Diestsepoort 1, 3000 Leuven
Associate
Director
Director
Director
Director
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Diestsepoort 1, 3000 LeuvenCurrent | accounts 2023 → 2025 | Accounts 2025 · 2026-00551807 |
| Groenveldstraat 13, 3001 Heverlee | accounts 2022 | Accounts 2022 · 2023-00236977 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| VITAMINS@WORKCurrent | accounts 2022 → 2025 | Accounts 2025 · 2026-00551807 |
Events
- 2025Annual accounts 2025-539,3 k €↓
- 2024Annual accounts 2024-285,7 k €↓
- 2023Annual accounts 2023-276,8 k €↓
- 2022Annual accounts 2022-69,3 k €
- 18/03/2022IncorporationPrivate limited company